Becton Dickinson (NY:BDX)

198.91 -1.51 (-0.75%)

Official Closing Price Updated: 7:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

'Halftime Report' Traders Share Their Thoughts On Leslie's, Zynga And More ↗

August 24, 2021

On CNBC's "Fast Money Halftime Report," Josh Brown said he is still holding Leslie's Inc (NASDAQ: LESL) and he still believes in it. He may even add to his long...

Via Benzinga

JPMorgan Downgrades Becton Dickinson On Muffled FY22 Outlook ↗

August 06, 2021

JPMorgan downgraded Becton Dickinson and Co (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021 ↗

August 06, 2021

Upgrades According to Wolfe Research, the prior rating for The AES Corp (NYSE:

Via Benzinga

ROCE Insights For Becton ↗

May 10, 2021

Looking at Q2, Becton (NYSE:BDX) earned $434.00 million, a 65.03% increase from the preceding quarter. Becton's sales decreased to $4.91 billion, a 7.68% change since Q1. Becton...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

August 06, 2021

Piper Sandler boosted the price target for Moderna, Inc. (NASDAQ: MRNA) from $246 to $445. Moderna shares fell 1.6% to $409.55 in pre-market trading. Needham cut the price...

Via Benzinga

Becton, Dickinson and Company (BDX) Q3 2021 Earnings Call Transcript ↗

August 05, 2021

BDX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

BDX Stock Plunges Despite Q3 Earnings Topping Estimates On Recovery In Elective Volumes; Raised FY21 Guidance ↗

August 05, 2021

Becton Dickinson and Co (NYSE: BDX) reported Q3 revenues of $4.9 billion, +26.9% Y/Y, better than the consensus of $4.51 billion. The increase is primarily driven by...

Via Benzinga

Becton, Dickinson: Q3 Earnings Insights ↗

August 05, 2021

Shares of Becton, Dickinson (NYSE:BDX) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were up 24.55% year over year to $2....

Via Benzinga

Price Over Earnings Overview: Becton, Dickinson ↗

August 03, 2021

Looking into the current session, Becton, Dickinson Inc. (NYSE:BDX) shares are trading at $257.45, after a 0.52% gain. Moreover, over the past month, the stock...

Via Benzinga

3 Dividend Stocks Safe Enough to Bet the Farm On ↗

July 29, 2021

You shouldn't invest your life savings into any one stock, but these three have some serious potential.

Via The Motley Fool

2 Cheap Dividend Stocks You Can Buy Right Now ↗

June 23, 2021

There's a good chance your dividend income will rise over the years with these two investments.

Via The Motley Fool

4 Top Dividend Aristocrats To Add To Your Retirement Portfolio ↗

May 31, 2021

Amid the current market volatility on concerns over rising inflation, we think it is wise to invest in the shares of dividend aristocrats, given their long history of increasing dividends.

Via Talk Markets

Topics Retirement

3 Dividend Stocks That Are Safer Investments Than AT&T ↗

May 25, 2021

Low payout ratios and tons of cash make these stocks solid income investments that you can buy and forget about.

Via The Motley Fool

15 Dividend Aristocrats For Long-Term Dividend Growth ↗

May 20, 2021

The best dividend stocks to buy and hold over the long term have a number of key characteristics in common. They have leadership positions in their industry, which provides for steady profits each...

Via Talk Markets

Topics Economy

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

Becton Dickinson To Build Fourth Facility In Spain To Expand Pre-Filled Drug Delivery Business ↗

May 18, 2021

Becton Dickinson and Co (NYSE: BDX) will build a €165 million ($200 million) high-tech manufacturing facility in Zaragoza, Spain, that will create up to 600...

Via Benzinga

MedTech Round Up: Update On Johnson & Johnson, Becton Dickinson, Labcorp, Second Sight Medical, Biocept ↗

May 13, 2021

Johnson & Johnson's (NYSE: JNJ) Vision segment has won FDA approval for the first contact lenses designed to reshape the cornea curve and help treat...

Via Benzinga

Becton Dickinson & Co. (BDX) Q2 2021 Earnings Call Transcript ↗

May 06, 2021

BDX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Becton Dickinson To Spin-Off Diabetes Care Business: Highlights ↗

May 06, 2021

While reporting financial results for the second fiscal quarter of the year, during which revenues grew more than 15% to $4.9 billion, Becton Dickinson and Co...

Via Benzinga

BDX Q2 Earnings Top Estimates, Reports $480M COVID-19 Diagnostic Sales; Reaffirms FY21 Guidance ↗

May 06, 2021

Becton Dickinson and Co (NYSE: BDX) reported Q2 revenues of $4.91 billion, an increase of 15.4% Y/Y, slightly better than the consensus of $4.89 billion. The...

Via Benzinga

Recap: Becton, Dickinson Q2 Earnings ↗

May 06, 2021

Shares of Becton, Dickinson (NYSE:BDX) decreased 0.4% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 25.10%...

Via Benzinga

SPACs Attack Recap: 5 Deals, Rumors And Headline News ↗

April 18, 2021

It was another busy week for the SPAC market with numerous deal announcements and rumored deals. Benzinga's "SPACs Attack" covered it all throughout the week. Here...

Via Benzinga

Bill Gates-Backed Vicarious Surgical Announces SPAC Deal With D8 Holdings: What You Need To Know ↗

April 15, 2021

Vicarious Surgical Inc. announced a SPAC merger on Thursday that will bring the next-gen robotics company to the public markets. The SPAC Deal: Vicarious Surgical is going public...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.